BackStrategic Trust - Kelly CRISPR & Gene Editing Technology ETF Overview

Strategic Trust - Kelly CRISPR & Gene Editing Technology ETF Current Assets

See how XDNA's current assets trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow
Current Assets
N/A

Peer average

Loading

Strategic Trust - Kelly CRISPR & Gene Editing Technology ETF Current Assets History

Loading

Strategic Trust - Kelly CRISPR & Gene Editing Technology ETF vs. peers: Current Assets Comparison

Loading

Strategic Trust - Kelly CRISPR & Gene Editing Technology ETF Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Strategic Trust - Kelly CRISPR & Gene Editing Technology ETF (XDNA) FAQ

Stockcircle tracks current assets for Strategic Trust - Kelly CRISPR & Gene Editing Technology ETF (XDNA), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Current Assets page is built for Strategic Trust - Kelly CRISPR & Gene Editing Technology ETF's historical current assets trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use current assets as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main XDNA overview so you can move from this figure to the surrounding analysis quickly.